NCT05254795View on ClinicalTrials.gov

Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

April 13, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2036

Conditions
Non-Small Cell Lung Cancer
Interventions
OTHER

Molecular tumor board assisted care

Participants in this group will obtain recommendations for care from the molecular tumor board.

Trial Locations (1)

40506

RECRUITING

University of Kentucky, Lexington

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Timothy Mullett

OTHER